Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85.6M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+51.7K
-
Total reported value, excl. options
-
$160M
-
Value change
-
+$976K
-
Put/Call ratio
-
0
-
Number of buys
-
27
-
Number of sells
-
-20
-
Price
-
$4.13
Significant Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q4 2022
60 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 85.6M outstanding shares and own 45.27% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (16.9M shares), CHI Advisors LLC (3.47M shares), PERCEPTIVE ADVISORS LLC (2.86M shares), Woodline Partners LP (1.94M shares), Opaleye Management Inc. (1.56M shares), Verition Fund Management LLC (1.48M shares), MANGROVE PARTNERS (1.29M shares), GREAT POINT PARTNERS LLC (1.27M shares), VANGUARD GROUP INC (1.09M shares), and JANUS HENDERSON GROUP PLC (927K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.